Experimental drug targets debilitating 'Brain Fog' in lupus patients
NCT ID NCT07281105
Summary
This study tested whether a drug called EG-501 could improve thinking and memory problems, often called 'brain fog,' in people with lupus. 131 adults with lupus and confirmed cognitive impairment were randomly assigned to receive either EG-501 or a placebo (inactive substance) for 12 weeks. Researchers measured changes in memory, attention, and other thinking skills to see if the drug was safe and effective for this serious symptom with no currently approved treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
UT Health Houston
Houston, Texas, 77030, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.